CaliPharms, Inc. Stock price

Equities

KGET

US4984561021

Pharmaceuticals

Market Closed - OTC Markets 10:25:53 2024-03-21 am EDT 5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for CaliPharms, Inc. 0.00% 0.00%
Sales 2012 - Sales 2013 - Capitalization 8.23M
Net income 2012 - Net income 2013 - EV / Sales 2012 * -
Net Debt 2012 617K Net Debt 2013 667K EV / Sales 2013 -
P/E ratio 2012 *
-
P/E ratio 2013
-0.51 x
Employees -
Yield 2012 *
-
Yield 2013
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Current year
0.00
Extreme 0
0.00
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.00
5 years
0.00
Extreme 0
0.00
10 years
0.00
Extreme 0
0.01
More quotes
Date Price Change Volume

Delayed Quote OTC Markets, March 21, 2024 at 10:25 am EDT

More quotes
CaliPharms Inc is a developmental stage acquisition company. The Company is focused on acquiring, merging, and joint venturing with legally permitted fully operational marijuana-cannabis businesses. The Company is seeking acquisitions in medical marijuana-cannabis cultivation. The Company focuses on the medical-grade marijuana-cannabis within the State of California. The Company is also expanding into other sectors that support the legalized marijuana industry.
More about the company
  1. Stock
  2. Equities
  3. Stock CaliPharms, Inc. - OTC Markets